For the quarter ended February 2026, Neogen (NEOG) reported revenue of $211.2 million, down 4.4% over the same period last year. EPS came in at $0.09, compared to $0.10 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $204.46 million, representing a surprise of +3.3%. The company delivered an EPS surprise of +125%, with the consensus EPS estimate being $0.04.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Neogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Animal Safety: $54.5 million versus the three-analyst average estimate of $56.02 million. The reported number represents a year-over-year change of -20.2%. Revenues- Food Safety: $156.7 million compared to the $148.11 million average estimate based on three analysts. The reported number represents a change of +2.6% year over year. Revenues- Food Safety- Indicator Testing, Culture Media & Other: $83 million versus the two-analyst average estimate of $81.18 million. The reported number represents a year-over-year change of +6.8%. Revenues- Animal Safety- Life Sciences: $1.5 million versus the two-analyst average estimate of $1.55 million. The reported number represents a year-over-year change of -0.3%. Revenues- Animal Safety- Veterinary Instruments & Disposables: $15.5 million versus $15.38 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +0.6% change. Revenues- Animal Safety- Animal Care & Other: $5.9 million versus the two-analyst average estimate of $9.61 million. The reported number represents a year-over-year change of -43.8%. Revenues- Food Safety- Natural Toxins & Allergens: $17.9 million versus the two-analyst average estimate of $17.65 million. The reported number represents a year-over-year change of +1.7%. Revenues- Animal Safety- Genomics Services: $16.6 million versus the two-analyst average estimate of $3.34 million. The reported number represents a year-over-year change of -2.4%. Revenues- Food Safety- Genomics Services: $6.2 million compared to the $11.34 million average estimate based on two analysts. The reported number represents a change of +8.9% year over year. Revenues- Food Safety- Biosecurity Products: $3.9 million versus the two-analyst average estimate of $4.29 million. The reported number represents a year-over-year change of -67%. Revenues- Food Safety- Bacterial & General Sanitation: $42.1 million versus $40.39 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.6% change. Revenues- Animal Safety- Biosecurity Products: $15 million compared to the $18.96 million average estimate based on two analysts. The reported number represents a change of -37.1% year over year.View all Key Company Metrics for Neogen here>>>
Shares of Neogen have returned +4.9% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Free Report: Profiting from the 2nd Wave of AI Explosion
The next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.
Investors who bought shares like Nvidia at the right time have had a shot at huge gains.
But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.
Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.
Access AI Boom 2.0 now, absolutely free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Neogen Corporation (NEOG): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).